Researchers have completed a clinical trial suggesting that the antidepressant drug fluvoxamine may help prevent deterioration in COVID-19 patients, making hospitalization less likely.
Click here for original story, Fluvoxamine may prevent serious illness in COVID-19 patients, study suggests
Source: ScienceDaily